Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices 37149

1. semiannual progress reports;

2. financial status report, no more

than 90 days after the end of the budget

period; and

3. final financial and performance

reports, no more than 90 days after the

end of the project period.

Send all reports to the Grants

Management Specialist identified in

Section J., ‘‘Where to Obtain Additional

Information.’’

The following additional

requirements are applicable to this

program. For a complete description of

each, see Attachment I in the

application kit.

AR 1 Human Subjects Requirements

AR 2 Requirements for Inclusion of

Women and Racial and Ethic

Minorities in Research

AR 10 Smoke-Free Workplace

Requirements

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

AR–14 Accounting System

Requirements

AR–15 Proof of Non-Profit Status

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under the

sections 301(a) and 317(k)(2) the Public

Health Service Act, [42 U.S.C. 241(a)

and 247b(k)(2)], as amended. The

Catalogue of Federal Domestic

Assistance number is 93.283.

J. Where To Obtain Additional

Information

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888–472–6874). You will be asked to

leave your name and address and will

be instructed to identify the

Announcement number of interest.

If you have questions after reviewing

the contents of all the documents,

business management assistance may be

obtained from: Barry Copeland, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office Announcement 00069,

Centers for Disease Control and

Prevention, Room 3000, 2920

Brandywine Road, Atlanta, GA 30341–

4146, Telephone (770) 488–2762, Email: bjc8@cdc.gov.

This and other CDC announcements

can be found on the CDC home page

Internet address—http://www.cdc.gov.

Click on Funding then click on Grants

and Cooperative Agreements.

For program technical assistance,

contact: Mike Waller, Centers for

Disease Control and Prevention,

Division of Adult and Community

Health, National Center for Chronic

Disease Prevention and Health

Promotion, 4770 Buford Highway NE,

Atlanta, GA, 30341–3717, Telephone:

(770) 488–5264, E-mail: mnw1@cdc.gov.

Dated: June 6, 2000.

Henry S. Cassel III,

Deputy Director, Procurement and Grants

Office, Center for Disease Control and

Prevention (CDC).

[FR Doc. 00–14832 Filed 6–12–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 00062]

Postdoctoral Fellowship Training

Program in Infectious Diseases; Notice

of Availability of Funds; Amendment

A notice announcing the availability

of Fiscal Year 2000 funds for a

cooperative agreement program for

Postdoctoral Fellowship Training

Programs in Infectious Diseases was

published in the Federal Register on

June 7, 2000, [Vol. 65, No. 110, Pages

36145–36148]. The notice is amended as

follows:

On page 36147, Second Column,

Under Section F. Submission and

Deadline, Letter of Intent (LOI), change

to read the ‘‘In order to assist CDC in

planning the evaluation of applications

submitted under this Program

Announcement, all parties intending to

submit an application are requested to

submit an LOI to inform CDC of their

intention to do so on or before June 23,

2000. Also, on page 36147, Second

Column, Under Section F. Submission

and Deadline, Application, change to

read: On or before Friday, July 7, 2000,

submit the application to the Grants

Management Specialist identified in the

‘‘Where to Obtain Additional

Information’’ section of this

announcement.

Dated: June 7, 2000.

Henry S. Cassell, III,

Acting Director, Procurement and Grants

Office Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–14834 Filed 6–12–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 01007]

Grants for Injury Control Research

Centers; Notice of Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2001

funds for Injury Control Research Center

(ICRC) grants. This program addresses

the ‘‘Healthy People 2010’’ priority

areas of Injury Prevention,

Unintentional Injury Prevention, and

Violence and Abuse Prevention. For the

conference copy of ‘‘Healthy People

2010,’’ visit the Internet site: http://

www.health.gov/healthypeople.

The purposes of this program are:

1. To support injury prevention and

control research on priority issues as

delineated in: Healthy People 2010;

Injury Control in the 1990’s: A National

Plan for Action; Reducing the Burden of

Injury: Advancing Prevention and

Treatment; Injury in America; Injury

Prevention: Meeting the Challenge; Cost

of Injury: A Report to the Congress; and

any list of research priorities published

by the National Center for Injury

Prevention and Control (NCIPC);

2. To integrate, in the context of a

national program, the disciplines of

engineering, epidemiology, medicine,

biostatistics, public health, law and

criminal justice, and behavioral and

social sciences in order to prevent and

control injuries more effectively;

3. To support the identification and

description of injury problems, to

identify risk and protective factors that

can be used to design and test injury

prevention and control strategies, to

evaluate current and new interventions

for the prevention and control of

injuries, and to support the

implementation of effective prevention

and control strategies in the public and

private sector; and

4. To provide technical assistance to

injury prevention and control programs

within a geographic region.

B. Eligible Applicants

This announcement will provide

funding for applicants in regions which

do not have funded Injury Control

Research Centers (ICRCs) and for

applicants in regions which have

funded centers which must re-compete

for funding.

Eligible applicants include all

nonprofit and for-profit organizations in

37150 Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices

Regions 1, 2, 5, 6, 7, 8, and 9. Thus,

universities, colleges, research

institutions, hospitals, other public and

private organizations, State and local

health departments, and small, minority

and/or women-owned businesses are

eligible for these grants. Non-academic

applicant institutions should provide

evidence of a collaborative relationship

with an academic institution.

Eligible applicants are limited to

organizations in Region 1 (Connecticut,

Maine, Massachusetts, New Hampshire,

Rhode Island, and Vermont), Region 2

(New Jersey, New York, Puerto Rico,

and Virgin Islands), Region 5 (Illinois,

Indiana, Michigan, Minnesota, Ohio,

and Wisconsin), Region 6 (Arkansas,

Louisiana, New Mexico, Oklahoma, and

Texas), Region 7 (Iowa, Kansas,

Missouri, and Nebraska), Region 8

(Colorado, Montana, North Dakota,

South Dakota, Utah, and Wyoming), and

Region 9 (Arizona, California, Hawaii,

Nevada, American Samoa, Guam,

Mariana Islands, Marshall Islands,

Micronesia, and Palau).

Note: ICRC grant awards are made to the

applicant institution/organization, not the

Principal Investigator.

Note: Public Law 104–65 states that an

organization described in section 501(c)(4) of

the Internal Revenue Code of 1986 that

engages in lobbying activities is not eligible

to receive Federal funds constituting an

award, grant, cooperative agreement,

contract, loan, or any other form.

C. Availability of Funds

Approximately $3,622,000 is expected

to be available in FY 2001 to fund

approximately four awards. It is

expected that the average award will be

$905,500 (total of direct and indirect

costs). It is expected that the awards

will begin on or around September 1,

2001, and will be made for a 12 month

budget period within a project period of

up to five years. Applications that

exceed the funding cap of $905,500 will

be excluded from the competition and

returned to the applicant. Funding

estimates may change. Continuation

awards within an approved project

period will be made on the basis of

satisfactory progress as evidenced by

required reports and the availability of

funds.

Use of Funds

Center funding is to be designated for

two types of activities. One type of

activity is considered ‘‘Core’’ and

includes administration, management,

general support services (e.g. statistical,

library, media relations, and advocacy)

as well as activities associated with

research development, technical

assistance, and education (e.g. seed

projects, training activities, and

collaborative and technical assistance

activities with other groups). Funds may

be allocated for trainee stipends, tuition

remission, and trainee travel, in

accordance with the current rates for the

Public Health agencies. Indirect costs

for these trainee-related activities are

limited to 8.0 percent. Defined research

projects constitute the second type of

activity, and ICRCs are encouraged to

work toward addressing the breadth of

the field. Core activities and defined

research projects may each constitute

between 25 percent–75 percent of the

operating budget and should be

balanced in such a way that the ICRC

demonstrates productivity in research as

well as teaching and service. Applicants

with less demonstrated expertise in

research are encouraged to devote a

larger percentage of funds to defined

research projects in order to establish

their capability as research centers of

excellence.

Grant funds will not be made

available to support the provision of

direct care. Studies may be supported

which evaluate methods of care and

rehabilitation for potential reductions in

injury effects and costs. Studies can be

supported which identify the effect on

injury outcomes and cost of systems for

pre-hospital, hospital, and rehabilitative

care and independent living.

Eligible applicants may enter into

contracts, including consortia

agreements (as set forth in the PHS

Grants Policy Statement, dated April 1,

1994), as necessary to meet the

requirements of the program and

strengthen the overall application.

Funding Preferences

Funding preference will be given to

re-competing ICRCs. These centers

represent a long term investment for

NCIPC and an established resource for

Injury Control related issues for their

States and regions.

D. Program Requirements

The following are applicant

requirements:

1. Applicants must demonstrate

expertise and conduct research projects

in at least one of the three phases of

injury control (prevention, acute care, or

rehabilitation) and are encouraged to be

comprehensive.

2. Applicants must document ongoing

injury-related research projects or

control activities currently supported by

other sources of funding.

3. Applicants must provide a director

(Principal Investigator) who has specific

authority and responsibility to carry out

the project. The director must report to

an appropriate institutional official, e.g.,

dean of a school, vice president of a

university, or commissioner of health.

The director must have no less than 30

percent effort devoted solely to this

project with an anticipated range of 30

percent—50 percent.

4. Applicants must demonstrate

experience in successfully conducting,

evaluating, and publishing injury

research and/or designing,

implementing, and evaluating injury

control programs.

5. Applicants must provide evidence

of working relationships with outside

agencies and other entities which will

allow for implementation of any

proposed intervention activities.

6. Applicants must provide evidence

of involvement of specialists or experts

in medicine, engineering, epidemiology,

law and criminal justice, behavioral and

social sciences, biostatistics, and/or

public health as needed to complete the

plans of the center. These are

considered the disciplines and fields for

ICRCs. An ICRC is encouraged to

involve biomechanicists in its research.

This, again, may be achieved through

collaborative relationships as it is not a

requirement that all ICRCs have

biomechanical engineering expertise.

7. Applicants must have established

curricula and graduate training

programs in disciplines relevant to

injury control (e.g., epidemiology,

biomechanics, safety engineering, traffic

safety, behavioral sciences, or

economics).

8. Applicants must demonstrate the

ability to disseminate injury control

research findings, translate them into

interventions, and evaluate their

effectiveness.

9. Applicants must have an

established relationship, demonstrated

by letters of agreement, with injury

prevention and control programs or

injury surveillance programs being

carried out in the region in which the

ICRC is located. Cooperation with

private-sector programs, e.g. ‘‘Safe

USA’’ partnerships, is encouraged.

10. Applicants should have an

established or documented planned

relationship with organizations or

individual leaders in communities

where injuries occur at high rates, e.g.,

minority communities.

E. Application Content

Use the information in the Program

Requirements, Other Requirements, and

Evaluation Criteria sections to develop

the application content. Applications

should include the following

information:

1. Face page

2. Description (abstract) and

personnel

Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices 37151

3. Table of contents

4. Detailed budget for the initial

budget period: The budget should

reflect the composite figures for the

grant. In addition, separate budgets

(direct and indirect costs) and

justifications should be provided for the

following categories of activities:

a. Core activities, including

management and administrative

functions, other non-research activities

(e.g. education/training, consultation,

technical assistance, translation/

dissemination, program and policy

development and evaluation, advocacy,

and media activities, etc.), and small

seed projects of less than $15,000 for a

one year period or less.

b. Research Studies:

(1) Small studies of $15,000–75,000

for each, of one to three years duration.

These projects might be expansions of

seed projects, either further developing

methods or hypotheses in preparation

for a larger investigation leading to the

submission of an RO1 level proposal, or

may be stand-alone investigations

sufficient to yield results worthy of

publication in a peer-reviewed journal

and/or a technical report for a legislative

body, governmental agency, or injury

control program.

(2) Larger scale studies with annual

budgets exceeding $75,000 and lasting

up to five years. These projects typically

will test hypotheses and employ more

sophisticated methodologies and/or

larger sample sizes than small studies.

For seed projects, only modest

descriptions are required within the

application and/or clear definition of

procedures used to select the projects.

More detailed descriptions,

commensurate with costs, are required

for both small studies and larger scale

projects.

5. Budget for entire proposed project

period including budgets pertaining to

consortium/contractual arrangements.

6. Biographical sketches of key

personnel, consultants, and

collaborators, beginning with the

Principal Investigator and core faculty.

7. Other support: This listing should

include all other funds or resources

pending or currently available. For each

grant or contract include source of

funds, amount of funding (indicate

whether pending or current), date of

funding (initiation and termination),

and relationship to the proposed

program.

8. Resources and environment.

9. Research plan:

a. ICRCs are to develop a range of

research and other non-research

activities that are designed to advance

the field of injury control through

development of new scientific or

surveillance methods, creation of new

knowledge, and translation of

knowledge into training, program and

policy development and evaluation

activities or other applications that will

ultimately reduce injuries or their

effects. ICRC applications should

articulate how the activities of their

program are integrated with each other

so as to demonstrate the whole of the

ICRCs activities and their potential

impact.

b. A detailed research plan (design

and methods) including hypothesis and

expected outcome, value to field, and

specific, measurable, and time-framed

objectives consistent with the activities

for each project within the proposed

grant.

(1) Seed projects require a short write

up describing the injury control context

of the study, the objective, the design,

the setting and participants, the

intervention being addressed, main

outcome measurements, expected

results, time lines, cost (direct and

indirect), and plans for translation/

dissemination, and/or clear definition of

procedures used to select the projects.

(2) Small research projects require a

10–15 page write up describing the

accomplishment of all the steps,

including the development and testing

of methods, the instruments, and the

collection of preliminary data, needed

to take an innovative approach and

develop it to the level of a larger

investigation leading to the submission

of an RO1 level proposal or a standalone investigation sufficient to yield

results worthy of publication in a peerreviewed journal and/or a technical

report for a legislative body,

governmental agency, or injury control

program.

(3) Large research projects require an

RO1 level write up as described in the

PHS 398 (Rev. 4/98) guidelines and

should be included as appendices of the

application.

(4) A detailed evaluation plan which

should address outcome and costeffectiveness evaluations as well as

formative, efficacy, and process

evaluation.

Include in the narrative for each small

research project and large project in the

research plan section of the application:

(1) Title of Project

(2) Project Director/Lead Investigator

(3) Institution(s)

(4) Categorization as to ‘‘Prevention,

Acute Care, Rehabilitation, or

Biomechanics’’

(5) Categorization as to ‘‘Seed Project,

Small Project, or Large Project’’

(6) Categorization as to ‘‘New or

Ongoing Project’’

(7) Cost/Year (Direct and Indirect)

(8) Research Training? Names,

Degrees of Persons Trained or in

Training

(9) Key Words

(10) Brief Summary of Project

including Intended Application of

Finding (Abstract)

c. A description of the core faculty

and its role in implementing and

evaluating the proposed programs. The

applicant should clearly specify how

disciplines will be integrated to achieve

the ICRCs objectives.

d. Charts showing the proposed

organizational structure of the ICRC and

its relationship to the broader

institution of which it is a part, and,

where applicable, to affiliate institutions

or collaborating organizations. These

charts should clearly detail the lines of

authority as they relate to the center or

the project, both structurally and

operationally. ICRC directors should

report to an appropriate organizational

level (e.g. dean of a school, vice

president of a university, or

commissioner of health), demonstrating

strong institution-wide support of ICRC

activities and ensuring oversight of the

process of interdisciplinary activity.

e. Documentation of the involved

public health agencies and other public

and private sector entities to be

involved in the proposed program,

including letters that detail

commitments of support and a clear

statement of the role, activities, and

participating personnel of each agency

or entity.

An applicant organization has the

option of having specific salary and

fringe benefit amounts for individuals

omitted from the copies of the

application which are made available to

outside reviewing groups. To exercise

this option: on the original and five

copies of the application, the applicant

must use asterisks to indicate those

individuals for whom salaries and fringe

benefits are not shown; the subtotals

must still be shown. In addition, the

applicant must submit an additional

copy of page four of Form PHS–398,

completed in full, with the asterisks

replaced by the salaries and fringe

benefits. This budget page will be

reserved for internal staff use only.

F. Submission and Deadline

Submit the original and five copies of

PHS 398 (OMB Number 0925–0001)and

adhere to the instructions on the Errata

Instruction sheet for PHS 398). Forms

are in the application kit.

On or before November 1, 2000,

submit the application to the Grants

Management Specialist identified in the

Where to Obtain Additional Information

section of this announcement.

37152 Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices

Applications shall be considered as

meeting the deadline if they are either:

1. Received on or before the deadline

date; or

2. Sent on or before the deadline date

and received in time for submission to

the independent review group.

Applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a legibly dated receipt from a

commercial carrier or the U.S. Postal

Service. Private metered postmarks shall

not be acceptable as proof of timely

mailing.

Late Applications: Applications

which do not meet the criteria in (1.) or

(2.) above are considered late

applications, will not be considered,

and will be returned to the applicant.

G. Evaluation Criteria

Upon receipt, applications will be

reviewed by CDC staff for completeness

and responsiveness as outlined under

the previous heading Program

Requirements. Incomplete applications

and applications that are not responsive

will be returned to the applicant

without further consideration.

Applications which are complete and

responsive may be subjected to a

preliminary evaluation (triage) by the

Injury Research Grant Review

Committee (IRGRC) to determine if the

application is of sufficient technical and

scientific merit to warrant further

review by the IRGRC. CDC will

withdraw from further consideration

applications judged to be

noncompetitive and promptly notify the

principal investigator/program director

and the official signing for the applicant

organization. Those applications judged

to be competitive will be further

evaluated by a dual review process.

Awards will be made based on

priority scores assigned to applications

by the IRGRC, programmatic priorities

and needs determined by a secondary

review committee (the Advisory

Committee for Injury Prevention and

Control), and the availability of funds.

1. Review by the Injury Research Grants

Review Committee (IRGRC)

Initial peer review of ICRC grant

applications will be conducted by the

IRGRC, which will recommend the

application for further consideration or

not for further consideration. For those

applications recommended for further

consideration, a team of peer reviewers,

including members of the IRGRC, will

conduct on-site visits at each applicant

institution, generate summary

statements for the visits, and report its

assessment to the IRGRC.

Factors to be considered by the IRGRC

include:

a. The specific aims of the

application, e.g., the long-term

objectives and intended

accomplishments. Approval of research

projects (including new research

projects proposed during the five year

funding cycle) is subject to peer review.

(1) Seed projects will be evaluated

collectively on the mechanism for

solicitation of projects, on the technical/

scientific merit review, and on the

selection and monitoring of projects.

(2) Small projects will be evaluated

individually on the innovative approach

and proposed methods for achieving an

investigation sufficient to support a

submission of an RO1 level proposal

and/or worthy of publication in a peerreviewed journal and/or a technical

report for a legislative body,

governmental agency, or injury control

program.

(3) Large projects will be evaluated

individually according to existing RO1

level project standards as described in

the PHS 398 (Rev. 4/98) guidelines. An

application must have a minimum of

three large research projects approved in

order to be recommended for further

consideration.

b. The scientific and technical merit

of the overall application, including the

significance and originality (e.g., new

topic, new method, new approach in a

new population, or advancing

understanding of the problem) of the

proposed research.

c. The extent to which the evaluation

plan will allow for the measurement of

progress toward the achievement of

stated application objectives.

d. Qualifications, adequacy, and

appropriateness of personnel to

accomplish the proposed activities.

e. The soundness of the proposed

budget in terms of adequacy of

resources and their allocation.

f. In addition to conducting defined

research projects, ICRCs are expected to

devote substantial attention to activities

directed at advancing the field through

other activities that are designed to

improve research capabilities and

translate research into practice.

Examples of such activities include

consultation and technical assistance

that are responsive to regional and state

priorities, professional training for

researchers and practitioners, program

development, and evaluation endeavors.

The degree of effort devoted to these

aspects of an ICRCs program should be

clearly stated in the justification and the

budget. The degree of effort may be

varied and should reflect the specific

focus and goals of the ICRC.

g. Details of progress in the most

recent funding period should be

provided in the application if the

applicant is submitting a re-competing

application. Documented examples of

success include: development of pilot

projects; completion of high quality

research projects; publication of

findings in peer reviewed scientific and

technical journals; number of

professionals trained; ongoing provision

of consultation and technical assistance;

integration of disciplines; translation of

research into implementation; impact

on injury control outcomes including

legislation, regulation, treatment, and

behavior modification interventions.

h. Does the application adequately

address the requirements of Title 45

CFR Part 46 for the protection of human

subjects?

i. Does the applicant meet the CDC

Policy requirements regarding the

inclusion of women, ethnic, and racial

groups in the proposed research?

j. Does the application adequately

address the requirements of the ‘‘PHS

Policy on Humane Care and Use of

Laboratory Animals by Awardee

Institutions?’

2. Review by the CDC Advisory

Committee for Injury Prevention and

Control (ACIPC)

Secondary review of ICRC grant

applications will be conducted by the

Science and Program Review Work

Group (SPRWG) of the ACIPC. The

SPRWG consists of ACIPC members,

Federal ex officio participants, and

organizational liaisons. The Federal ex

officio participants will be responsible

for identifying proposals in overlapping

areas of research interest so that

unwarranted duplication in federallyfunded research can be avoided. The

NCIPC Division Associate Directors for

Science (ADS) or their designees will

address the SPRWG to assure that

research priorities of the announcement

are understood and to provide

background regarding current research

activities. These recommendations will

be presented to the entire ACIPC in the

form of a report by the Chairman of the

SPRWG. The ACIPC will vote to

approve, disapprove, or modify these

recommendations for funding

consideration.

These recommendations, based on the

results of the review by the IRGRC, the

relevance and balance of the proposed

research relative to the NCIPC programs

and priorities, and the assurance of no

duplication of federally-funded

research, are presented to the Director,

NCIPC, for funding decisions.

Factors to be considered by the ACIPC

include:

a. The results of the peer review.

b. The significance of the proposed

activities as they relate to national

Federal Register / Vol. 65, No. 114 / Tuesday, June 13, 2000 / Notices 37153

program priorities, geographic balance,

and the achievement of national

objectives.

c. The overall balance of the ICRC

program in addressing the three phases

of injury control (prevention, acute care,

and rehabilitation); the control of injury

among populations who are at increased

risk, including racial/ethnic minority

groups, the elderly and children; the

major causes of intentional and

unintentional injury; and the major

disciplines of injury control (such as

biomechanics, epidemiology, and

behavioral science).

d. Budgetary considerations. The

ACIPC will recommend annual funding

levels as detailed under the heading,

Availability of Funds.

3. Continued Funding

Continuation awards within the

project period will be made on the basis

of the availability of funds and the

following criteria:

a. The accomplishments of the current

budget period show that the applicant’s

objectives as prescribed in the yearly

work plans are being met;

b. The objectives for the new budget

period are realistic, specific, and

measurable;

c. The methods described will clearly

lead to achievement of these objectives;

d. The evaluation plan allows

management to monitor whether the

methods are effective by having clearly

defined process, impact, and outcome

objectives, and the applicant

demonstrates progress in implementing

the evaluation plan; and

e. The budget request is clearly

explained, adequately justified,

reasonable, and consistent with the

intended use of grant funds.

H. Other Requirements

Technical Reporting Requirements

Provide CDC with original plus two

copies of

1. progress report annually;

2. financial status report, no more

than 90 days after the end of the budget

period; and

3. final financial status report and

performance report, no more than 90

days after the end of the project period.

Send all reports to the Grants

Management Specialist identified in the

Where to Obtain Additional Information

section of this announcement.

The following additional

requirements are applicable to this

program. For a complete description of

each see Addendum 1 in the application

kit.

AR–1 Human Subjects Certification

AR–2 Requirements for inclusion of

Women and Racial and Ethnic

Minorities in Research

AR–3 Animal Subjects Requirements

AR–9 Paperwork Reduction Act

Requirements

AR–10 Smoke-Free Workplace

Requirement

AR–11 Healthy People 2010

AR–12 Lobbying Restrictions

AR–13 Prohibition on Use of CDC

funds for Certain Gun Control

Activities

AR–20 Conference Activities within

Grants/Cooperative Agreements

I. Authority and Catalog of Federal

Domestic Assistance Number

This program is authorized under

Sections 301, 391, 392, 393, and 394 of

the Public Health Service Act, [42

U.S.C. 241, 280b, 280b–1, 280b–1a, and

280b–2] as amended. Catalog of Federal

Domestic Assistance number is 93.136.

J. Where To Obtain Additional

Information

For this announcement and other CDC

announcements, see the CDC home page

on the Internet: http://www.cdc.gov.

To receive additional written

information and to request an

application kit, call 1–888–GRANTS4

(1–888–472–6874). You will be asked to

leave your name and address and will

be instructed to identify the

Announcement number of interest. A

complete program description and

information on application procedures

are contained in the application

package.

If you have questions after reviewing

the contents of all the documents,

business management assistance may be

obtained from: Joanne Wojcik, Grants

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), Colgate

Building, Room 3000, 2920 Brandywine

Road, Atlanta, GA 30341–4146,

Telephone 770–488–2717, Internet

address: jcw6@cdc.gov

Programmatic assistance may be

obtained from: Tom Voglesonger,

Program Manager, Office of Research

Grants, National Center for Injury

Prevention and Control, Centers for

Disease Control and Prevention (CDC),

4770 Buford Highway, NE., (K58),

Atlanta, GA 30341–3724, Telephone

770–488–4265, Internet address:

tdv1@cdc.gov.

Please refer to Announcement 01007

when requesting information and

submitting an application.

Dated: June 7, 2000.

Henry S. Cassell, III,

Acting Director, Procurement and Grants

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–14831 Filed 6–12–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee for EnergyRelated Epidemiologic Research:

Conference Call Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following conference call

meeting.

Name: Advisory Committee for

Energy-Related Epidemiologic Research

(ACERER), Subcommittee for

Management Review of the Chernobyl

Studies (SMRCS).

Time and Date: 1 p.m.–1:30 p.m.,

June 26, 2000.

Place: The conference call will

originate at the National Center for

Environmental Health (NCEH), CDC, in

Atlanta, Georgia. Please see

SUPPLEMENTARY INFORMATION for details

on accessing the conference call.

Status: Open to the public, limited

only by the availability of telephone

ports.

Purpose: This subcommittee is

charged with providing guidance to the

scientific reviewers and staff, and

reporting back to the full ACERER on

the charge from the Department and

Congress to assess the management,

goals, and objectives of the National

Cancer Institute Chernobyl studies.

Matters To Be Discussed: The

conference call agenda is to reach

consensus on the review and report

submitted by the SRMCS.

Agenda items are subject to change as

priorities dictate.

SUPPLEMENTARY INFORMATION: This

conference call is scheduled to begin at

1 p.m., Eastern Time. To participate in

the conference call, please dial 1–877–

322–9654 and enter conference code

970943. You will then be automatically

connected to the call.

CONTACT PERSON FOR MORE INFORMATION:

Michael J. Sage, Executive Secretary,

ACERER, and Acting Deputy Director,

NCEH, CDC, 4770 Buford Highway, NE,

(F–28), Atlanta, Georgia 30341–3724,

telephone 770/488–7002, fax 770/488–

7015.